Olga Kryštůfková

859 total citations
36 papers, 458 citations indexed

About

Olga Kryštůfková is a scholar working on Epidemiology, Immunology and Molecular Biology. According to data from OpenAlex, Olga Kryštůfková has authored 36 papers receiving a total of 458 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 13 papers in Immunology and 12 papers in Molecular Biology. Recurrent topics in Olga Kryštůfková's work include Inflammatory Myopathies and Dermatomyositis (13 papers), Immunodeficiency and Autoimmune Disorders (7 papers) and Fibromyalgia and Chronic Fatigue Syndrome Research (5 papers). Olga Kryštůfková is often cited by papers focused on Inflammatory Myopathies and Dermatomyositis (13 papers), Immunodeficiency and Autoimmune Disorders (7 papers) and Fibromyalgia and Chronic Fatigue Syndrome Research (5 papers). Olga Kryštůfková collaborates with scholars based in Czechia, Sweden and Croatia. Olga Kryštůfková's co-authors include Jiří Vencovský, H. Mann, Hana Hulejová, Ingrid E. Lundberg, Ladislav Šenolt, Vivianne Malmström, Sevim Barbasso Helmers, Karel Pavelká, Jaromír Běláček and Lucie Andrés Cerezo and has published in prestigious journals such as Scientific Reports, Frontiers in Immunology and Annals of the Rheumatic Diseases.

In The Last Decade

Olga Kryštůfková

36 papers receiving 449 citations

Peers

Olga Kryštůfková
Martin Klein Czechia
Olga Kryštůfková
Citations per year, relative to Olga Kryštůfková Olga Kryštůfková (= 1×) peers Martin Klein

Countries citing papers authored by Olga Kryštůfková

Since Specialization
Citations

This map shows the geographic impact of Olga Kryštůfková's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olga Kryštůfková with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olga Kryštůfková more than expected).

Fields of papers citing papers by Olga Kryštůfková

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olga Kryštůfková. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olga Kryštůfková. The network helps show where Olga Kryštůfková may publish in the future.

Co-authorship network of co-authors of Olga Kryštůfková

This figure shows the co-authorship network connecting the top 25 collaborators of Olga Kryštůfková. A scholar is included among the top collaborators of Olga Kryštůfková based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olga Kryštůfková. Olga Kryštůfková is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leclair, Valérie, Antonella Notarnicola, Olga Kryštůfková, et al.. (2024). Effect modification of cancer on the association between dysphagia and mortality in early idiopathic inflammatory myopathies. Seminars in Arthritis and Rheumatism. 65. 152408–152408. 1 indexed citations
2.
Štorkánová, Hana, Sabína Oreská, Maja Špiritović, et al.. (2022). Hsp90 Levels in Idiopathic Inflammatory Myopathies and Their Association With Muscle Involvement and Disease Activity: A Cross-Sectional and Longitudinal Study. Frontiers in Immunology. 13. 811045–811045. 9 indexed citations
3.
Prajzlerová, Klára, Olga Kryštůfková, Petra Hánová, et al.. (2021). High miR-451 expression in peripheral blood mononuclear cells from subjects at risk of developing rheumatoid arthritis. Scientific Reports. 11(1). 4719–4719. 13 indexed citations
4.
Kryštůfková, Olga, et al.. (2021). Fever of unknown origin. Vnitřní lékařství. 67(1). e32–e42. 3 indexed citations
5.
Mann, H., Olga Kryštůfková, Josef Zámečnı́k, et al.. (2020). Interleukin-35 in idiopathic inflammatory myopathies. Cytokine. 137. 155350–155350. 5 indexed citations
6.
Hulejová, Hana, Kristýna Bubová, Olga Kryštůfková, et al.. (2019). Serum visfatin levels in patients with axial spondyloarthritis and their relationship to disease activity and spinal radiographic damage: a cross-sectional study. Rheumatology International. 39(6). 1037–1043. 6 indexed citations
7.
Cerezo, Lucie Andrés, Hana Hulejová, Barbora Šumová, et al.. (2019). Pro-inflammatory S100A11 is elevated in inflammatory myopathies and reflects disease activity and extramuscular manifestations in myositis. Cytokine. 116. 13–20. 22 indexed citations
8.
Vokurková, Martina, Martin Klein, Michal Tomčík, et al.. (2019). Alterations in activin A–myostatin–follistatin system associate with disease activity in inflammatory myopathies. Lara D. Veeken. 59(9). 2491–2501. 17 indexed citations
9.
Ramsköld, Daniel, Olga Kryštůfková, H. Mann, et al.. (2018). Effect of CTLA4‐Ig (abatacept) treatment on T cells and B cells in peripheral blood of patients with polymyositis and dermatomyositis. Scandinavian Journal of Immunology. 89(1). e12732–e12732. 12 indexed citations
10.
Kryštůfková, Olga, Hana Hulejová, H. Mann, et al.. (2018). Serum levels of B-cell activating factor of the TNF family (BAFF) correlate with anti-Jo-1 autoantibodies levels and disease activity in patients with anti-Jo-1positive polymyositis and dermatomyositis. Arthritis Research & Therapy. 20(1). 158–158. 30 indexed citations
11.
Šenolt, Ladislav, Olga Kryštůfková, Hana Hulejová, et al.. (2011). The level of serum visfatin (PBEF) is associated with total number of B cells in patients with rheumatoid arthritis and decreases following B cell depletion therapy. Cytokine. 55(1). 116–121. 32 indexed citations
12.
Freiberger, Tomáš, Hana Grombiříková, Barbora Ravčuková, et al.. (2011). No Evidence for Linkage between the Hereditary Angiooedema Clinical Phenotype and the BDKR1, BDKR2, ACE or MBL2 gene. Scandinavian Journal of Immunology. 74(1). 100–106. 12 indexed citations
13.
Šenolt, Ladislav, Hana Hulejová, Olga Kryštůfková, et al.. (2011). Low circulating Dickkopf-1 and its link with severity of spinal involvement in diffuse idiopathic skeletal hyperostosis. Annals of the Rheumatic Diseases. 71(1). 71–74. 48 indexed citations
14.
Kryštůfková, Olga, Sevim Barbasso Helmers, Vivianne Malmström, & Ingrid E. Lundberg. (2011). Receptors for B cell activating factor of the TNF Family (BAFF) are expressed in muscle tissue of myositis patients with anti–Jo-1 or anti–Ro 52/anti–Ro 60 autoantibodies and correlate with plasmacytoid dendritic cell markers. Annals of the Rheumatic Diseases. 70. A64–A65. 1 indexed citations
15.
Kryštůfková, Olga, Therese Vallerskog, Sevim Barbasso Helmers, et al.. (2008). Increased serum levels of B cell activating factor (BAFF) in subsets of patients with idiopathic inflammatory myopathies. Annals of the Rheumatic Diseases. 68(6). 836–843. 91 indexed citations
16.
Veigl, David, et al.. (2007). Periprosthetic osteolysis and its association with RANKL expression. Physiological Research. 56(4). 455–462. 22 indexed citations
17.
Houbiers, J. G. A., Jiří Vencovský, Š Rùzicková, et al.. (2007). Endogenous HLA–DR–restricted presentation of the cartilage antigens human cartilage gp‐39 and melanoma inhibitory activity in the inflamed rheumatoid joint. Arthritis & Rheumatism. 56(7). 2150–2159. 18 indexed citations
18.
Freiberger, Tomáš, et al.. (2002). Exon 1 polymorphism of the B2BKR gene does not influence the clinical status of patients with hereditary angioedema. Human Immunology. 63(6). 492–494. 18 indexed citations
19.
Kryštůfková, Olga, et al.. (2001). Intracellular expression of CXCR3 on rheumatoid arthritis synovial tissue cells. Arthritis Research & Therapy. 3(S2). 2 indexed citations
20.
Bartůňková, Jiřina, et al.. (1995). [Diagnostic and pathogenic significance of antineutrophil cytoplasmic antibodies in vasculitides].. PubMed. 96(10). 528–33. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026